Drug Trial Radar · NCT02747927
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
Last checked: Nov 19, 2026Latest source record: Nov 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20,099
Actual
Start
Apr 26, 2016
Primary completion
Jul 11, 2018
Study completion Jun 28, 2024
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Apr 22, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 4 years, up to 16 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The main purpose of this study is to evaluate the efficacy of 2 doses of Tetravalent Dengue Vaccine Candidate (TDV) in preventing symptomatic dengue fever of any severity and due to any of the four dengue virus serotypes in 4 to 16 year old participants.
Conditions
- Healthy Volunteers
Interventions
PlaceboDrug
TDV placebo-matching SC injection.
Tetravalent Dengue Vaccine (TDV)Biological
TDV SC injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Vaccine Efficacy (VE) of Two Doses of Tetravalent Dengue Vaccine Candidate (TDV) in Preventing Virologically-Confirmed Dengue Fever Induced by Any Dengue SerotypeTime frame: 30 days post-second vaccination (Day 120 [Month 4]) until the end of Part 1 (Month 15) when at least 120 cases of dengue fever were confirmed and minimum duration of participant follow-up was 12 months post-second vaccination
Locations
28 sites in 8 countries. Site status is shown where the registry gives one.
Universidade Federal Do Espirito Santo Hospital Universitario Cassiano Antonio de Moraes HUCAM
Vitória, Espírito Santo, Brazil
Associacao Obras Sociais Irma Dulce Hospital Santo Antonio
Salvador, Estado de Bahia, Brazil
Universidade Federal de Mato Grosso do Sul
Campo Grande, Mato Grosso do Sul, Brazil
Centro de Estudos e Pesquisa em Molestias Infecciosas LTDA (CPCLIN)
Cidade Alta, Natal - RN, Brazil
Centro de Atencion e Investigacion Medica S.A - CAIMED - Aguazul - PPDS-PV
Aguazul, Casanare Department, Colombia
Centro de Atencion e Investigacion Medica S.A - CAIMED - Yopal - PPDS-PV
Yopal, Casanare Department, Colombia
Centro de Atencion e Investigacion Medica S.A. - CAIMED - Acacias - PPDS-PV
Acacías, Meta Department, Colombia
Centro de Estudios em Infectologia Pediatrica SAS (CEIP S.A.S)
Cali, San Fernando, Colombia
Hospital Maternidad Nuestra Senora de Altagracia
Santo Domingo, Distrito Nacional Santo Domingo, Dominican Republic
Calle Alexander Fleming No. 90 Esquina 37, Ensanche La Fe
Santo Domingo, Distrito Nacional Santo Domingo, Dominican Republic
Universidad Nacional Autonoma de Nicaragua
León, Nicaragua
Centro De Vacunacion Internacional, S.A. (Cevaxin)
Panama City, Panama
Centro De Vacunacion Internacional, S.A. (Cevaxin) Sede 24 de Diciembre
Panama City, Panama
Centro De Vacunacion Internacional, S.A. (Cevaxin) Sede Plaza Carolina
Panama City, Panama
Centro De Vacunacion Internacional, S.A.(Cevaxin) - La Chorrera
Panama City, Panama
Research Institute for Tropical Medicine
City of Muntinlupa, Philippines
University of the Philippine Manila
Ermita, Philippines
Las Pinas Health Center A
Las Piñas, Philippines
Las Pinas Health Center D
Las Piñas, Philippines
Dela Salle Health Sciences Institute
Dasmariñas, Cavite, Philippines
Philippines-AFRIMS Virology Research Unit
Cebu City, Cebu, Philippines
Lady Ridgeway Hospital for Children
Colombo, Sri Lanka
Colombo South Teaching Hospital
Dehiwala, Sri Lanka
Negombo General Hospital
Negombo, Sri Lanka
Colombo North Teaching Hospital
Ragama, Sri Lanka
Srinagarind Hospital
Khon Kaen, Thailand
The Hospital for Tropical Diseases
Bangkok, Bangkok, Thailand
Phramongkutklao Hospital
Bangkok, Bangkok, Thailand
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.